Up-to-date access to technology licensing opportunities worldwide.
Displaying 1..3 of 3 -
per page
Order by
In-licensing injectables andoral medicines for the hospital market, originals for orphan/nichemarkets
More
Phase III and beyond prescription products are sought to in-license into the four major Nordic countries.
More
Leiras Finland is looking to in-license new prescription products for the Nordic region including Finland, Sweden, Norway and Denmark.
More
Displaying 1..3 of 3 -
per page
Order by
Apr 2008 - 250 pages - $3,995
Apr 2010 - 510 pages - $2,695
Sep 2011 - 65 pages - $5,700
Apr 2006 - 310 pages - $3,500
Oct 2010 - 92 pages - $5,700
Apr 2011 - 90 pages - $3,800
Nov 2010 - 83 pages - $5,700
Dec 2010 - 88 pages - $11,400
Oct 2010 - 53 pages - $1,000
Aug 2010 - 98 pages - $5,700